333 related articles for article (PubMed ID: 26091719)
1. Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.
Spaan AN; Schiepers A; de Haas CJ; van Hooijdonk DD; Badiou C; Contamin H; Vandenesch F; Lina G; Gerard NP; Gerard C; van Kessel KP; Henry T; van Strijp JA
J Immunol; 2015 Aug; 195(3):1034-43. PubMed ID: 26091719
[TBL] [Abstract][Full Text] [Related]
2. Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.
Tromp AT; Van Gent M; Abrial P; Martin A; Jansen JP; De Haas CJC; Van Kessel KPM; Bardoel BW; Kruse E; Bourdonnay E; Boettcher M; McManus MT; Day CJ; Jennings MP; Lina G; Vandenesch F; Van Strijp JAG; Lebbink RJ; Haas PA; Henry T; Spaan AN
Nat Microbiol; 2018 Jun; 3(6):708-717. PubMed ID: 29736038
[TBL] [Abstract][Full Text] [Related]
3. The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.
Spaan AN; Henry T; van Rooijen WJM; Perret M; Badiou C; Aerts PC; Kemmink J; de Haas CJC; van Kessel KPM; Vandenesch F; Lina G; van Strijp JAG
Cell Host Microbe; 2013 May; 13(5):584-594. PubMed ID: 23684309
[TBL] [Abstract][Full Text] [Related]
4. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
Adhikari RP; Kort T; Shulenin S; Kanipakala T; Ganjbaksh N; Roghmann MC; Holtsberg FW; Aman MJ
PLoS One; 2015; 10(9):e0137874. PubMed ID: 26367030
[TBL] [Abstract][Full Text] [Related]
6. α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureus.
Cardot-Martin E; Casalegno JS; Badiou C; Dauwalder O; Keller D; Prévost G; Rieg S; Kern WV; Cuerq C; Etienne J; Vandenesch F; Lina G; Dumitrescu O
Lett Appl Microbiol; 2015 Aug; 61(2):158-64. PubMed ID: 25963798
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus Panton-Valentine Leukocidin triggers an alternative NETosis process targeting mitochondria.
Mazzoleni V; Zimmermann K; Smirnova A; Tarassov I; Prévost G
FASEB J; 2021 Feb; 35(2):e21167. PubMed ID: 33241563
[TBL] [Abstract][Full Text] [Related]
8. The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors.
Spaan AN; Vrieling M; Wallet P; Badiou C; Reyes-Robles T; Ohneck EA; Benito Y; de Haas CJ; Day CJ; Jennings MP; Lina G; Vandenesch F; van Kessel KP; Torres VJ; van Strijp JA; Henry T
Nat Commun; 2014 Nov; 5():5438. PubMed ID: 25384670
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome.
Holzinger D; Gieldon L; Mysore V; Nippe N; Taxman DJ; Duncan JA; Broglie PM; Marketon K; Austermann J; Vogl T; Foell D; Niemann S; Peters G; Roth J; Löffler B
J Leukoc Biol; 2012 Nov; 92(5):1069-81. PubMed ID: 22892107
[TBL] [Abstract][Full Text] [Related]
10. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
[TBL] [Abstract][Full Text] [Related]
11. TPST2-mediated receptor tyrosine sulfation enhances leukocidin cytotoxicity and
He J; Yang X; Yang K; Xu H; Chen C; Wang J; Zeng J
Front Immunol; 2023; 14():1242330. PubMed ID: 37671153
[TBL] [Abstract][Full Text] [Related]
12. Convergent Evolution of Neutralizing Antibodies to Staphylococcus aureus γ-Hemolysin C That Recognize an Immunodominant Primary Sequence-Dependent B-Cell Epitope.
Hernandez DN; Tam K; Shopsin B; Radke EE; Law K; Cardozo T; Torres VJ; Silverman GJ
mBio; 2020 Jun; 11(3):. PubMed ID: 32546616
[No Abstract] [Full Text] [Related]
13. Targeting NLRP3 and Staphylococcal pore-forming toxin receptors in human-induced pluripotent stem cell-derived macrophages.
Chow SH; Deo P; Yeung ATY; Kostoulias XP; Jeon Y; Gao ML; Seidi A; Olivier FAB; Sridhar S; Nethercott C; Cameron D; Robertson AAB; Robert R; Mackay CR; Traven A; Jin ZB; Hale C; Dougan G; Peleg AY; Naderer T
J Leukoc Biol; 2020 Sep; 108(3):967-981. PubMed ID: 32531864
[TBL] [Abstract][Full Text] [Related]
14. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
Kaneko J; Kamio Y
Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
[TBL] [Abstract][Full Text] [Related]
15. Host-Receptor Post-Translational Modifications Refine Staphylococcal Leukocidin Cytotoxicity.
Tromp AT; Van Gent M; Jansen JP; Scheepmaker LM; Velthuizen A; De Haas CJC; Van Kessel KPM; Bardoel BW; Boettcher M; McManus MT; Van Strijp JAG; Lebbink RJ; Haas PA; Spaan AN
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32041354
[TBL] [Abstract][Full Text] [Related]
16. Modelling staphylococcal pneumonia in a human 3D lung tissue model system delineates toxin-mediated pathology.
Mairpady Shambat S; Chen P; Nguyen Hoang AT; Bergsten H; Vandenesch F; Siemens N; Lina G; Monk IR; Foster TJ; Arakere G; Svensson M; Norrby-Teglund A
Dis Model Mech; 2015 Nov; 8(11):1413-25. PubMed ID: 26398950
[TBL] [Abstract][Full Text] [Related]
17. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model.
Karauzum H; Adhikari RP; Sarwar J; Devi VS; Abaandou L; Haudenschild C; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Warfield KL; Shulenin S; Aman MJ
PLoS One; 2013; 8(6):e65384. PubMed ID: 23762356
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Active Immunization With Attenuated α-Hemolysin and Panton-Valentine Leukocidin in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia.
Tran VG; Venkatasubramaniam A; Adhikari RP; Krishnan S; Wang X; Le VTM; Le HN; Vu TTT; Schneider-Smith E; Aman MJ; Diep BA
J Infect Dis; 2020 Jan; 221(2):267-275. PubMed ID: 31504652
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the Pathological Role of Staphylococcal α-Toxin and Panton-Valentine Leukocidin Using a Novel
Olaniyi RO; Pancotto L; Grimaldi L; Bagnoli F
Front Immunol; 2018; 9():951. PubMed ID: 29867940
[No Abstract] [Full Text] [Related]
20. Serum antibodies against Panton-Valentine leukocidin in a normal population and during Staphylococcus aureus infection.
Croze M; Dauwalder O; Dumitrescu O; Badiou C; Gillet Y; Genestier AL; Vandenesch F; Etienne J; Lina G
Clin Microbiol Infect; 2009 Feb; 15(2):144-8. PubMed ID: 19154491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
